市场调查报告书
商品编码
1447121
到 2030 年安瓿和泡壳包装市场预测:按包装类型、材料、最终用户和地区进行的全球分析Ampoules and Blister Packaging Market Forecasts to 2030 - Global Analysis By Packaging Type (Ampoules and Blister), By Material (Plastic, Glass, Aluminium and Other Materials), End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球安瓿和泡壳包装市场规模为 141 亿美元,预计在预测期内将以 7.3% 的复合年增长率增长,到 2030 年达到 231 亿美元。
安瓿是小型密封管瓶,用于封装和储存单剂量的液体药物。泡壳包装由塑胶片或铝片组成,每个泡壳包含单剂量的产品。两种包装方法均可确保剂量准确、保护药物免受外部影响并维持产品完整性。
根据《2018年能源展望》,65岁及以上人口比例预计将从2016年的10%以上增加到2025年的14%以上。
对防篡改包装的需求增加
对防篡改包装的需求不断增长是安瓿和泡壳包装市场的关键驱动因素。砸道机篡改功能透过指示包装是否已开启或损坏,为消费者提供产品完整性的保证。在医学和医疗保健领域,这对于确保药物的安全性和有效性至关重要。随着人们对产品安全性和真实性的担忧不断增加,安瓿和泡壳包装越来越多地采用砸道机篡改包装,以满足消费者的期望和监管要求。
监管挑战
有关药品包装的严格法规要求遵守有关安全、标籤和品质保证的特定标准。满足多样化的国际合规要求既复杂又耗时,这可能会影响产品开发时间表并增加营运成本。此外,不断变化的监管条件可能需要不断调整包装方法。此外,保持合规性变得至关重要,并且限制了设计和材料的弹性。
药品需求增加
製药业的扩张增加了对可靠、高效的包装解决方案的需求,以确保药品的安全性和完整性。安瓿或泡壳包装可实现安全、准确的剂量,同时保护产品免受外部因素的影响。对这些包装解决方案不断增长的需求正在推动市场参与者参与不断扩大的製药行业,推动行业成长和创新。
环境友好和永续包装
随着人们对环境问题的认识不断增强,对环保替代品的需求也不断增加。塑胶和铝等传统包装材料会导致环境恶化。安瓿和泡壳包装产业必须透过开发减少废弃物和碳足迹的永续解决方案来适应具有环保意识的消费者偏好。如果无法解决这些问题,可能会导致市场占有率下降并阻碍市场成长。
COVID-19 大流行加速了对药品的需求,从而影响了安瓿和泡壳包装市场。人们对医疗保健和疫苗分发的日益关注增加了对安全高效包装解决方案的需求。为了应对大流行带来的挑战,该行业经历了优先事项和生产需求的转变,其中一个显着的重点是确保基本药物的安全可靠的包装。
预计铝业在预测期内将成为最大的行业
由于铝材具有优异的阻隔性能、重量轻和可回收性,预计在预测期内将主导安瓿和泡壳包装市场。铝包装有效地防止外部因素的影响,并确保药品的完整性。此外,其永续性符合世界对环保包装解决方案日益重视的趋势。这些因素使铝成为安瓿和泡壳包装市场的首选材料。
预计製药和医疗保健产业在预测期内的复合年增长率最高
预计在预测期内,製药和医疗保健领域的安瓿和泡壳包装市场将实现最高成长。这一增长的推动因素包括全球药品需求的增加、对医疗保健基础设施的日益关注以及对安全高效包装解决方案的需求。安瓿和泡壳包装在药品储存和运输中的重要作用有助于该细分市场的持续成长和突出。
在强劲的製药业、先进的医疗基础设施以及对研发的高度重视的推动下,北美预计将引领安瓿和泡壳包装市场。该地区严格的监管标准确保了对安全、合规的包装解决方案的需求。此外,对病人安全的日益重视、创新的给药系统和成熟的製造业也有助于北美的领先地位。该地区的经济实力和对技术进步的承诺进一步巩固了其作为市场主要参与者的地位。
由于製药和医疗保健行业的扩张、人口的成长和可支配收入的增加,亚太地区是安瓿和泡壳包装市场成长率最高的地区。该地区的製药业正在经历显着成长,推动了对安全高效包装解决方案的需求。此外,政府倡议、技术进步和蓬勃发展的电子商务产业正在加速安瓿和泡壳包装的采用,使亚太地区成为预测期内的主要成长市场。
According to Stratistics MRC, the Global Ampoules and Blister Packaging Market is accounted for $14.1 billion in 2023 and is expected to reach $23.1 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Ampoules are small, sealed vials used to contain and preserve a single dose of a liquid medication. Blister packaging consists of a sheet of plastic or aluminum with individual compartments, or blisters, each holding a single dosage of a product. Both packaging methods ensure accurate dosage delivery and protect pharmaceuticals from external influences, maintaining product integrity.
According to the Energy Source Outlook 2018, the proportion of the population above 65 years of age is expected to cross 14% by the year 2025 from over 10% in 2016.
Increasing demand for tamper-evident packaging
The rising demand for tamper-evident packaging is a significant driver in the ampoules and blister packaging markets. Tamper-evident features provide consumers with assurance of product integrity by indicating if the packaging has been opened or compromised. In pharmaceuticals and healthcare, this is crucial for ensuring the safety and effectiveness of medications. As concerns about product security and authenticity grow, the adoption of tamper-evident packaging in ampoules and blister packaging is increasing to meet consumer expectations and regulatory requirements.
Regulatory challenges
Stringent regulations governing pharmaceutical packaging demand adherence to specific standards for safety, labeling, and quality assurance. Meeting diverse international compliance requirements can be complex and time-consuming, impacting product development timelines and increasing operational costs. Additionally, evolving regulatory landscapes may necessitate constant adjustments to packaging practices. Moreover, maintaining compliance becomes a crucial aspect, limiting flexibility in design and materials.
Increasing demand for pharmaceutical products
Due to the expansion of the pharmaceutical industry globally, there is a growing need for reliable and efficient packaging solutions to ensure the safety and integrity of medications. Ampoules and blister packaging offer secure and precise dosing while protecting products from external factors. The increasing demand for these packaging solutions positions market players to capitalize on the expanding pharmaceutical sector, fostering growth and innovation in the industry.
Environmental concerns and sustainable packaging
With heightened awareness of ecological issues, there's a growing demand for eco-friendly alternatives. Traditional packaging materials, such as plastic and aluminum, contribute to environmental degradation. The ampoules and blister packaging industry must adapt to eco-conscious consumer preferences by developing sustainable solutions that reduce waste and carbon footprints. Failure to address these concerns may lead to market share loss which hinders market growth.
The COVID-19 pandemic has influenced the ampoules and blister packaging market by accelerating the demand for pharmaceutical products. Increased focus on healthcare and vaccine distribution has heightened the need for secure and efficient packaging solutions. The industry has experienced shifts in priorities and production demands to meet the challenges posed by the pandemic, with a notable emphasis on ensuring the safe and reliable packaging of essential pharmaceuticals.
The aluminium segment is expected to be the largest during the forecast period
The aluminum segment is anticipated to dominate the ampoules and blister packaging market during the forecast period due to its exceptional barrier properties, lightweight nature, and recyclability. Aluminum packaging offers effective protection against external factors, ensuring the integrity of pharmaceutical products. Additionally, its sustainability aligns with the increasing global emphasis on eco-friendly packaging solutions. These factors contribute to the continued prominence of the aluminum segment, making it a preferred material in the ampoules and blister packaging market.
The pharmaceuticals and healthcare segment is expected to have the highest CAGR during the forecast period
The pharmaceuticals and healthcare segment is projected to achieve the highest growth in the ampoules and blister packaging market during the forecast period. This growth is driven by the rising global demand for pharmaceutical products, the increased focus on healthcare infrastructure, and the need for secure and efficient packaging solutions. The critical role of ampoules and blister packaging in preserving and delivering medications contributes to the sustained growth and prominence of this segment in the market.
North America is poised to lead the ampoules and blister packaging market, fueled by a robust pharmaceutical industry, advanced healthcare infrastructure, and a strong focus on research and development. The region's stringent regulatory standards ensure the demand for secure and compliant packaging solutions. Additionally, a growing emphasis on patient safety, innovative drug delivery systems, and a well-established manufacturing sector contribute to North America's leadership. The region's economic strength and commitment to technological advancements further solidify its position as a key player in the market.
Asia Pacific is poised for the highest growth rate in the ampoules and blister packaging market due to expanding pharmaceutical and healthcare sectors, an increasing population and rising disposable incomes. The region's pharmaceutical industry is witnessing significant growth, driving the demand for secure and efficient packaging solutions. Additionally, government initiatives, technological advancements, and a burgeoning e-commerce sector contribute to the accelerated adoption of ampoules and blister packaging, making Asia Pacific a key growth market in the forecast period.
Key players in the market
Some of the key players in Ampoules and Blister Packaging Marketinclude Amcor Limited, AptarGroup, Inc., Becton, Dickinson and Company (BD), Constantia Flexibles Group GmbH, Gerresheimer AG, Intrapac International Corporation, Klockner Pentaplast Group, Kuraray Co., Ltd., MeadWestvaco Corporation, Nipro Corporation, Romaco Noack , RPC Group Plc, SCHOTT AG, Sonoco Products Company, West Pharmaceutical Services, Inc., WestRock Company and Wipak Group.
In January 2024, Kuraray Europe GmbH (KEG) (a 100% owned subsidiary of Kuraray Co., Ltd.; Headquarters: Frankfurt, Germany; President: Dr. Matthias Gutweiler; hereinafter "KEG") announces the establishment of a new European subsidiary, Kuraray Europe Spain S.L., to reinforce KEG's networks in Europe and accelerate future market development in the Iberian Peninsula.
In December 2023, Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced the opening of its new Aptar Mumbai site, which will increase manufacturing capabilities in South East Asia.
In January 2023, Romaco Noack introduced the Unity 600 blister packaging line, offering improved sustainability, process reliability, and performance. The monobloc features an innovative transfer unit for enhanced traceability and format flexibility. With a maximum output of 600 blisters and 350 cartons per minute, the line achieves high-speed production.